Cencora has announced the completion of its name and stock ticker change from AmerisourceBergen Corporation, marking the latest stage of the company’s evolution as a leader in global pharmaceutical services.
Under the new name Cencora, the company unifies its 46,000 employees – across several global business segments – under one identity, propelled by a bold vision and purpose-driven approach to creating healthier futures.
The new name underscores Cencora’s experience and vision when it comes to connecting manufacturers, providers, pharmacies and patients, and ensuring the consistent, reliable flow of treatments to those who need them at a time of growing complexity.
“This is a significant and exciting milestone for Cencora. Our new name is a reminder of our customers, their patients and our team members who are at the centre of everything we do,” said Steven H. Collis, Chairman, President and Chief Executive Officer of Cencora. “It represents the healthier futures we strive for serving as a trusted industry partner that prioritises innovation, advocates for patient access and advances strategic partnerships across the global pharmaceutical value chain.”